Protalix Biotherapeutics Inc's Customers Performance

Name: Protalix Biotherapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PLX

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PLX's Source of Revenues		During the corresponding time, Protalix Biotherapeutics Inc recorded a revenue increase by 27.07 % year on year, sequentially revenue fell by -41.05 %. While revenue at the Protalix Biotherapeutics Inc 's corporate clients • List of PLX Customers

for the same period Protalix Biotherapeutics Inc recorded revenue increase by 27.07 % year on year, sequentially revenue fell by -41.05 %.

• List of PLX Customers

Protalix Biotherapeutics Inc's Business Units


Product	99.66 %	of total Revenue
License and Service	0.34 %	of total Revenue
Single operating segment	100 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Protalix Biotherapeutics Inc's Comment on Sales, Marketing and Customers

The company serves customers including Pfizer Inc., Chiesi Farmaceutici S.p.A., and Fundação Oswaldo Cruz (Fiocruz), an entity of the Brazilian Ministry of Health. It operates in the pharmaceutical and biotechnology sectors, providing services related to clinical trials and drug product supply. The company has a supply and technology transfer agreement with Fiocruz.

Protalix Biotherapeutics Inc’s Comment on Sales, Marketing and Customers

PLX's Stock Performance relative to it's Customers

PLX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Protalix Biotherapeutics inc	211.35	80.62	18.95	226
Pfizer Inc	167,778.56	63,696.00	4,370.00	75,000
SUBTOTAL	335,557.12	127,392.00	8,740.00	150,000

Sources: Protalix Biotherapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, October 15, 2026 5:23 AM
Focus of this report: Protalix Biotherapeutics inc’s corporate clients.
For your research, we’ve provided 9 tables on Protalix Biotherapeutics inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.